Trials / Completed
CompletedNCT04355403
Performance and Safety of Hyalo Gyn Gel on the Treatment of Vaginal Atrophy in Postmenopausal Women
A Prospective, Randomized, Controlled, Open-label Clinical Investigation to Assess the Performance and Safety of Hyalo Gyn Gel Prefilled Applicators on the Treatment of Vaginal Atrophy in Postmenopausal Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Fidia Farmaceutici s.p.a. · Industry
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This clinical investigation evaluates the performance and safety of Hyalo Gyn, a hyaluronic acid derivative based vaginal gel for the treatment of symptoms of vulvo-vaginal atrophy in post-menopausal women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hyalo Gyn gel in prefilled applicators | One vaginal application of Hyalo Gyn gel every 3 days to a total of 12 consecutive weeks. |
Timeline
- Start date
- 2019-02-05
- Primary completion
- 2019-06-28
- Completion
- 2019-06-28
- First posted
- 2020-04-21
- Last updated
- 2020-04-21
Locations
2 sites across 1 country: Slovakia
Source: ClinicalTrials.gov record NCT04355403. Inclusion in this directory is not an endorsement.